Nadine Landolina

4PUBLICATIONS
11CO-AUTHORS
Innate immunityMolecular medicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 27, 2025
IL-37/IL-1R8 axis: a novel major mechanism of control at the interface between tumor and immune cells.

Nadine Landolina, Francesca Romana Mariotti, Enrico Munari

|Feb 02, 2023
Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.

Ilan Zaffran, Nadine Landolina, Pratibha Gaur

|Jun 10, 2022
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.

Ilan Zaffran, Nadine Landolina, Pratibha Gaur

|Mar 16, 2022
IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells.

Nadine Landolina, Francesca Romana Mariotti, Tiziano Ingegnere

Pageof 1